Comparison

Naspm trihydrochloride European Partner

Item no. ALO-N-215-10mg
Manufacturer Alomone
CASRN 1049731-36-3
Amount 10 mg
Quantity options 10 mg 25 mg 50 mg 5 mg
Category
Type Small Molecules
Format Lyophilized
Specific against other
Purity >95% (HPLC)
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Non Antibodies
Manufacturer - Category
S. Molecules
Manufacturer - Targets
AMPA receptors
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage as Solution: Up to four weeks at 4°C or three months at -20°C. - Storage after Reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods (up to 6 months), small aliquots should be stored at -20°C. We do not recommend storing the product in working solutions for longer than a few days. Avoid multiple freeze-thaw cycles.
Molecular Weight
479, 91
Manufacturer - Format
Lyophilized powder.
Short description
An Antagonist of AMPA Receptors
Description
An Antagonist of AMPA Receptors
Reconstitution
50 mM in H2O. Centrifuge all product preparations before use (10000 x g for 1 min).
PH
7, 4
UNSPSC
41116134
Effective Concentration
300 nM - 10 µM.
Activity
Naspm trihydrochloride is a selective AMPA receptor antagonist; ~0.3 uM IC50 for AMPA induced currents in rat hipocampal neurons1.
Solubility
50 mM in H2O. Centrifuge all product preparations before use (10000 x g for 1 min).
Bioassay tested
Yes
Chemical Name
N-[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]-1-naphthaleneacetamide trihydrochloride.
Scientific Background
1-Naphthyl acetyl spermine (NASPM), a synthetic analogue of Joro spider toxin (JSTX), is a selective antagonist of Ca2+-permeable AMPA receptors. It blocks AMPA receptors lacking the GluR2 subunit expressed in rat hippocampal neurons with IC50 values of 0.33 μM1.NASPM has been shown to block excitatory synaptic potentials evoked by stimulation of parallel fibers in guinea pig cerebellar Purkinje cells. In the hippocampus, NASPM has been reported to exert a potent and selective suppression of hippocampal epileptic discharges mediated by non-NMDA receptors. In addition, it has been reported that EPSCs in CA1 neurons of the gerbil hippocampus after ischemia are mediated by Ca2+-permeable non-NMDA receptors, and that these abnormal EPSCs are effectively suppressed by NASPM.These data suggest that NASPM may be useful as a pharmacological tool for investigating the physiological and pathological roles of AMPA receptors, and furthermore, that it could be used as a parent compound to develop new agents for the treatment of neuronal cell death and epilepsy1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close